Monitoring, Medication, and When to Seek Help
Home blood pressure monitoring is essential for managing hypertension. Office blood pressure readings are subject to “white coat hypertension” (elevated readings in medical settings due to anxiety) and fail to capture the daily variation that is clinically important. Ambulatory blood pressure monitoring (worn device recording readings every 15-30 minutes for 24 hours) is considered the gold standard — it provides average daytime, nighttime, and 24-hour readings that better predict cardiovascular outcomes than office readings. Home monitoring with an upper-arm automated cuff (more accurate than wrist devices) twice daily (morning before medications/food, evening before dinner) for 7 days provides a reliable blood pressure average.
When medication is necessary: lifestyle changes take 4-12 weeks to produce maximal effect and may not be sufficient for all patients, particularly those with Stage 2 hypertension (≥140/90), cardiovascular disease, diabetes, or chronic kidney disease. Antihypertensive medications — including ACE inhibitors, ARBs, calcium channel blockers, and thiazide diuretics — are well-tolerated by most patients and reduce cardiovascular risk significantly. The decision to medicate should factor in absolute cardiovascular risk (total risk profile, not just blood pressure alone), side effect tolerance, and patient preferences. Importantly, starting medication does not preclude continuing lifestyle modifications, which can reduce medication dose or improve control when added to pharmacological treatment.
Target blood pressure for treatment: the SPRINT trial (2015) demonstrated that targeting systolic BP below 120mmHg (intensive treatment) reduced cardiovascular events by 25% and all-cause mortality by 27% compared to targeting below 140mmHg (standard treatment) in adults ≥50 with hypertension but without diabetes. This evidence drove updates to US guidelines recommending a target of below 130/80 mmHg for most adults with hypertension. For adults with diabetes, recent guidelines align on <130/80mmHg; for older adults (75+) with frailty, higher targets (140-150/90) may be appropriate to avoid hypotension complications. The optimal target is individually determined by physician assessment of total cardiovascular risk, age, comorbidities, and tolerance of treatment side effects.